Strategic partnerships Leverage Enzymotec’s position within the Frutarom Group and its joint venture InFat with AAK to target infant formula manufacturers and dietary supplement brands seeking lipid-based ingredients that resemble human milk fat and brain-boosting phospholipids.

Medical nutrition growth Explore expansion opportunities in the VAYA Pharma segment by engaging hospitals and specialty clinics focused on cardiovascular and neurological disorders, positioning branded lipid-based medical foods as clinically supported dietary management options.

Krill oil differentiation Capitalize on K-Real krill oil latest formulations that remove TMA/TMAO to engage clean-label oriented brands and wellness retailers seeking advanced lipid ingredients with safety and purity advantages.

Global flavor & ingredients link Utilize Frutarom’s global footprint to co-market Enzymotec lipid solutions to flavor and fine ingredient customers seeking functional lipids, enabling cross-selling into established Frutarom customer networks.

Growth through acquisitions Identify synergistic targets such as healthcare-focused distributors or end-user brands acquired or partnered by Enzymotec customers (e.g., Ushcare integration) to broaden distribution channels and accelerate market penetration in niche medical and dietary segments.